CLINICAL RESEARCH: HEART RHYTHM DISORDERS
Long QT Syndrome and Pregnancy
Rahul Seth, MD*,
Arthur J. Moss, MD*,*,
Scott McNitt, MS*,
Wojciech Zareba, MD, PhD*,
Mark L. Andrews, BBA*,
Ming Qi, PhD ,
Jennifer L. Robinson, MS*,
Ilan Goldenberg, MD*,
Michael J. Ackerman, MD, PhD ,
Jesaia Benhorin, MD ,
Elizabeth S. Kaufman, MD||,
Emanuela H. Locati, MD, PhD¶,
Carlo Napolitano, MD¶,
Silvia G. Priori, MD, PhD¶,
Peter J. Schwartz, MD#,
Jeffrey A. Towbin, MD**,
G. Michael Vincent, MD and
Li Zhang, MD
* Cardiology Division of the Department of Medicine
Department of Pathology, University of Rochester Medical Center, Rochester, New York
Departments of Medicine, Pediatrics, and Molecular Pharmacology, Mayo Clinic College of Medicine, Rochester, Minnesota
Department of Cardiology, Bikur Cholim Hospital, Jerusalem, Israel
|| The Heart and Vascular Research Center, MetroHealth Campus, Case Western Reserve University, Cleveland, Ohio
¶ Cardiovascular Department De Gasperis, Niguarda Hospital, Milan, ItalyMolecular Cardiology, Fondazione S. Maugeri
# Department of Cardiology, Policlinico S. Matteo IRCCS, University of Pavia, Pavia, Italy
** Department of Pediatric Cardiology, Baylor College of Medicine, Houston, Texas
Department of Medicine, University of Utah School of Medicine, Salt Lake City, Utah
Manuscript received May 15, 2006;
revised manuscript received September 14, 2006,
accepted September 27, 2006.
* Reprint requests and correspondence: Dr. Arthur J. Moss, Heart Research Follow-up Program Box 653, University of Rochester Medical Center, Rochester, New York 14642. (Email: heartajm{at}heart.rochester.edu).
Objectives: This study was designed to investigate the clinical course of women with long QT syndrome (LQTS) throughout their potential childbearing years.
Background: Only limited data exist regarding the risks associated with pregnancy in women with LQTS.
Methods: The risk of experiencing an adverse cardiac event, including syncope, aborted cardiac arrest, and sudden death, during and after pregnancy was analyzed for women who had their first birth from 1980 to 2003 (n = 391). Time-dependent Kaplan-Meier and Cox proportional hazard methods were used to evaluate the risk of cardiac events during different peripartum periods.
Results: Compared with a time period before a woman's first conception, the pregnancy time was associated with a reduced risk of cardiac events (hazard ratio [HR] 0.28, 95% confidence interval [CI] 0.10 to 0.76, p = 0.01), whereas the 9-month postpartum time had an increased risk (HR 2.7, 95% CI 1.8 to 4.3, p < 0.001). After the 9-month postpartum period, the risk was similar to the period before the first conception (HR 0.91, 95% CI 0.55 to 1.5, p = 0.70). Genotype analysis (n = 153) showed that women with the LQT2 genotype were more likely to experience a cardiac event than women with the LQT1 or LQT3 genotype. The cardiac event risk during the high-risk postpartum period was reduced among women using beta-blocker therapy (HR 0.34, 95% CI 0.14 to 0.84, p = 0.02).
Conclusions: Women with LQTS have a reduced risk for cardiac events during pregnancy, but an increased risk during the 9-month postpartum period, especially among women with the LQT2 genotype. Beta-blockers were associated with a reduction in cardiac events during the high-risk postpartum time period.
|
Abbreviations and Acronyms
| | ACA = aborted cardiac arrest | | CI = confidence interval | | ECG = electrocardiogram | | LQTS = long QT syndrome |
|
This article has been cited by other articles:
|
|
|
|
 
C. L. Shufelt and C. N. Bairey Merz
Contraceptive hormone use and cardiovascular disease.
J. Am. Coll. Cardiol.,
January 20, 2009;
53(3):
221 - 231.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. N. Johnson, N. Hofman, C. M. Haglund, G. D. Cascino, A.A.M. Wilde, and M. J. Ackerman
Identification of a possible pathogenic link between congenital long QT syndrome and epilepsy
Neurology,
January 20, 2009;
72(3):
224 - 231.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Presbitero, G. G. Boccuzzi, C. J.M. Groot, and J. W. Roos-Hesselink
CHAPTER 33 Pregnancy and Heart Disease
ESC Textbook of Cardiovascular Medicine,
January 1, 2009;
2(1):
med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. LEVINE, S. Z. ROSERO, A. S. BUDZIKOWSKI, A. J. MOSS, W. ZAREBA, and J. P. DAUBERT
Congenital long QT syndrome: Considerations for primary care physicians
Cleveland Clinic Journal of Medicine,
August 1, 2008;
75(8):
591 - 600.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. J. Moss and I. Goldenberg
Importance of Knowing the Genotype and the Specific Mutation When Managing Patients With Long-QT Syndrome
Circ Arrhythm Electrophysiol,
August 1, 2008;
1(3):
219 - 226.
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Goldenberg and A. J. Moss
Long QT syndrome.
J. Am. Coll. Cardiol.,
June 17, 2008;
51(24):
2291 - 2300.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. M. Scheinman and E. Keung
The Year in Review of Clinical Cardiac Electrophysiology
J. Am. Coll. Cardiol.,
May 27, 2008;
51(21):
2075 - 2081.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. M. Roden
Long-QT Syndrome
N. Engl. J. Med.,
January 10, 2008;
358(2):
169 - 176.
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Nakamura, J. Kurokawa, C.-X. Bai, K. Asada, J. Xu, R. V. Oren, Z. I. Zhu, C. E. Clancy, M. Isobe, and T. Furukawa
Progesterone Regulates Cardiac Repolarization Through a Nongenomic Pathway: An In Vitro Patch-Clamp and Computational Modeling Study
Circulation,
December 18, 2007;
116(25):
2913 - 2922.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
What's the Level of Cardiac Risk During and After Pregnancy in Women with Long-QT Syndrome?
Journal Watch Cardiology,
April 11, 2007;
2007(411):
4 - 4.
[Full Text]
|
|
|
|
